Liposomal and nonliposomal drug pharmacokinetics after administration of liposome-encapsulated vincristine and their contribution to drug tissue distribution properties

Journal of Pharmacology and Experimental Therapeutics

Volumn 298, Issue 3, 2001, Pages 1206-1212

  Krishna, Rajesh ^a,b,d   Webb, Murray S ^c   St Onge, Ginette ^a,e   Mayer, Lawrence D ^a,b  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Inex Pharmaceuticals Corporation   (Canada)

^d BRISTOL MYERS SQUIBB   (United States)

^e Celator Technologies Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DISTEAROYLGLYCERO 3 PHOSPHOCHOLINE; ANTINEOPLASTIC AGENT; CHOLESTEROL; LIPOSOME; PHOSPHORYLCHOLINE; SPHINGOMYELIN; UNCLASSIFIED DRUG; VINCRISTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG HALF LIFE; ENCAPSULATION; FEMALE; LEWIS CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; AREA UNDER CURVE; CARCINOMA, LEWIS LUNG; CHOLESTEROL; DRUG CARRIERS; FEMALE; INJECTIONS, INTRAVENOUS; LIPOSOMES; MICE; PHOSPHATIDYLCHOLINES; SPHINGOMYELINS; TISSUE DISTRIBUTION; VINCRISTINE;

EID: 0034893950     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. An information criterion
2. Controlling the drug delivery attributes of lipid-based drug formulations
3. Transfer of liposomal drug carriers from the blood to the peritoneal cavity of normal and ascitic tumorbearing mice
4. Treatment of vincristine extravasation
5. Encapsulation of vincristine in liposomes reduces its toxicity and improves its anti-tumor efficacy
6. Liposomal vincristine: The central role of drug retention in defining therapeutically optimized anticancer formulations
7. Liposomal vincristine which exhibits increased drug retention and increased circulation longevity cures mice bearing P388 tumors
8. Plant products in cancer chemotherapy
9. Selective in vivo localization of daunorubicin small unilamellar vesicles in solid tumors
10. Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes
11. Liposomal anthracyclines: Facing the clinical challenge
12. Relationships between tumor responsiveness, vincristine pharmacokinetics and arrest of mitosis in human tumor xenografts
13. Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice
14. Extravasation and transcytosis of liposomes in Kaposi's sarcoma-like dermal lesions of transgenic mice bearing the HIV tat gene
15. Intravenous vincristine infusion: Phase 1 trial
16. Treatment of advanced non-Hodgkin's lymphoma with vincristine infusion
17. Liposome encapsulated vincristine: Preclinical toxicologic and pharmacologic comparison with free vincristine and empty liposomes in mice, rats, and dogs
18. Liposomal vincristine preparations which exhibit decreased drug toxicity and increased activity against murine L1210 and P388 tumors
19. Preclinical and clinical studies with liposomal vincristine
20. Pharmacology of liposomal vincristine in mice bearing L1210 ascitic and B16/BL6 solid tumors
21. Identification of vesicle properties that enhance the antitumour activity of liposomal vincristine against murine L1210 leukemia
22. Determination of free and liposome-associated doxorubicin and vincristine levels in plasma under equilibrium conditions employing ultrafiltration techniques
23. Lipophilic platinum complexes entrapped in liposomes: Improved stability and preserved antitumor activity with complexes containing linear alkyl carboxylato leaving groups
24. Liposomal vincristine in relapsed non-Hodgkin's lymphomas: Early results of an ongoing phase II trial
25. Pharmacology of antitumor agents from higher plants
26. Sphingomyelincholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models
27. Preclinical pharmacology, toxicology and efficacy of sphingomyelin/cholesterol liposomal vincristine for therapeutic treatment of cancer